The global Behavioural Health Market brought in US$ 128.2 billion in revenue in 2017, and it is predicted that between 2022 and 2028, when its value will reach US$ 156.3 billion, it will increase at a 3.4% CAGR. North America is predicted to have the biggest revenue share in the global market for behavioural health …
Category Archives: Healthcare Trends
Muscle Stimulation Devices MarketExpanding at a healthy 3.9% CAGR, the size is projected to total US$ 874.4 Million by 2028
The Muscle Stimulation Devices Market sales are anticipated to reach US$ 694.7 Million in 2022. By 2028, the market is projected to develop at a strong CAGR of 3.9% and reach US$ 874.4 Million. witness incredibly significant advancements that may enhance stroke healing with nerve stimulation. The emphasis has turned to enhancing the related stages …
Gynaecological Examination Chairs Market is expected to reach US$ 852.3 Million by 2028, with sales revenue expected to register 6.9% CAGR
According to a Future Market Insights (FMI) analysis, the Gynaecological Examination Chairs Market is valued at US$ 531.6 Million in 2021 and is predicted to reach US$ 852.3 Million by 2028, representing a cumulative CAGR of 6.9% over the forecast period (2022-2028). In 2021, the global market for gynaecological examination chairs will account for around 38% of …
Demand for Ultrasound Systems Market in Western Europe is expected to register growth of 6.0% over the forecast period 2022 to 2028
According to the results of a global forecast mentioned in the report titled “Ultrasound Systems Market Global Industry Analysis 2012 to 2021 and Opportunity Assessment 2022 to 2028,” the global Ultrasound Systems Market is anticipated to reach a market value of over US$ 13.2 Billion by the end of 2028, growing at an impressive CAGR …
Japan Nucleic Acid Testing Market is projected to surpass US$ 525.6 Million by 2033 at a CAGR of 6.3%
The global Nucleic Acid Testing Market is expected to reach US$ 3.7 billion by 2023. The market is expected to reach US$ 7.2 billion by 2033, growing at a strong 6.8% CAGR. Major factors influencing the growth of the nucleic acid amplification testing market include the rising incidence of infectious diseases, cancers, and other diseases, improvements in …
Cellulite Treatment Market is anticipated to attain a valuation of US$ 5.2 Billion surge at a CAGR of 7.8% through 2028
A recent research report by Future industry Insights looks at the state of the worldwide cellulite treatment industry today and makes predictions for the years to come. The Cellulite Treatment Market is expected to grow rapidly, with a CAGR of 7.8%, reaching US$ 5.2 billion in 2028. This in-depth research report is titled Cellulite Treatment. …
Veterinary Lasers Market | Aesculight Llc, LiteCure LLC, Respond Systems, Inc., Pivotal Health Solutions | By 2028
The global Veterinary Lasers Market is predicted to take a leap from US$ 123.2 Million (2017) to a value worth US$ 336.5 Million by the end of 2028. Global demand for Veterinary Lasers Products projected to register the growth of 9.9% CAGR from 2022 to 2028, According to the latest market research report published on the global …
Western Europe’s Varicella Zoster Infection Treatment Market is forecasted to grow at a CAGR of 3.6% between 2022 to 2028
With a CAGR of 4.1% anticipated to reach US$ 2.05 billion by 2028, the global Varicella Zoster Infection Treatment Market is anticipated to be worth more than US$ 1.5 billion in 2020. Acyclovir will hold more than 55.7% of the market for the treatment of varicella zoster infection in 2022, predicts Future Market Insights. Secondary …
Gene Therapy in CNS Disorder Market Forecast 2023 to 2033 | By Type, Indication, End-Users & Region
The global Gene Therapy in CNS Disorders Market size is expected to reach US$ 8.2 billion in 2023 and US$ 103.04 billion by 2033, with a compound annual growth rate (CAGR) of 30% between 2023 and 2033. The market for gene therapy in CNS diseases grew at a 19% CAGR from 2018 to 2022. The …
Severe Asthma Treatment Market Forecast 2023 to 2033 | By AstraZeneca, GlaxoSmithKline, Novartis, Sanofi
According to Future Market Insights, the global Severe Asthma Treatment Market sales will expand at a 5.1% CAGR from 2023 to 2033, reaching US$ 36.18 billion by 2033. Severe Asthma Treatment has undergone a huge shift with the emergence of biologics and customised treatments, offering hope to millions of individuals worldwide who suffer from the …